Celon Pharma S.A. (CLN.WA)

PLN 23.85

(-7.38%)

Revenue Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual revenue in 2023 was 164.39 Million PLN , up 1.53% from previous year.
Celon Pharma S.A.'s latest quarterly revenue in 2024 Q2 was 53.58 Million PLN , up 47.54% from previous quarter.
Celon Pharma S.A. reported a annual revenue of 161.91 Million PLN in annual revenue 2022, down -4.51% from previous year.
Celon Pharma S.A. reported a annual revenue of 169.55 Million PLN in annual revenue 2021, up 21.75% from previous year.
Celon Pharma S.A. reported a quarterly revenue of 53.58 Million PLN for 2024 Q2, up 47.54% from previous quarter.
Celon Pharma S.A. reported a quarterly revenue of 42.5 Million PLN for 2023 Q3, up 0.64% from previous quarter.

Annual Revenue Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Revenue of Celon Pharma S.A. (2023 - 2012)

Year	Revenue	Revenue Growth
2023	164.39 Million PLN	1.53%
2022	161.91 Million PLN	-4.51%
2021	169.55 Million PLN	21.75%
2020	139.27 Million PLN	36.21%
2019	102.24 Million PLN	-18.36%
2018	125.24 Million PLN	16.92%
2017	107.12 Million PLN	-16.82%
2016	128.77 Million PLN	19.75%
2015	107.54 Million PLN	9.62%
2014	98.09 Million PLN	36.93%
2013	71.64 Million PLN	78.61%
2012	40.1 Million PLN	0.0%

Year	Revenue	Revenue Growth
2024 Q1	36.31 Million PLN	-10.68%
2024 Q2	53.58 Million PLN	47.54%
2023 Q3	42.5 Million PLN	0.64%
2023 Q1	39 Million PLN	-11.66%
2023 FY	164.39 Million PLN	1.53%
2023 Q2	42.22 Million PLN	8.26%
2023 Q4	40.66 Million PLN	-4.33%
2022 Q2	45.84 Million PLN	39.24%
2022 Q1	32.92 Million PLN	-15.99%
2022 FY	161.91 Million PLN	-4.51%
2022 Q4	44.15 Million PLN	13.24%
2022 Q3	38.99 Million PLN	-14.94%
2021 Q3	37.76 Million PLN	-23.17%
2021 FY	169.55 Million PLN	21.75%
2021 Q4	39.18 Million PLN	3.77%
2021 Q1	43.45 Million PLN	11.79%
2021 Q2	49.15 Million PLN	13.11%
2020 Q2	39.08 Million PLN	26.67%
2020 Q1	30.85 Million PLN	14.33%
2020 Q4	38.87 Million PLN	27.64%
2020 FY	139.27 Million PLN	36.21%
2020 Q3	30.45 Million PLN	-22.08%
2019 Q3	23.99 Million PLN	-0.7%
2019 Q1	27.09 Million PLN	-22.91%
2019 Q2	24.16 Million PLN	-10.79%
2019 FY	102.24 Million PLN	-18.36%
2019 Q4	26.98 Million PLN	12.46%
2018 Q3	31.69 Million PLN	4.82%
2018 Q2	30.24 Million PLN	7.36%
2018 Q1	28.16 Million PLN	8.7%
2018 Q4	35.14 Million PLN	10.87%
2018 FY	125.24 Million PLN	16.92%
2017 Q4	25.91 Million PLN	7.03%
2017 Q3	24.2 Million PLN	-15.38%
2017 FY	107.12 Million PLN	-16.82%
2017 Q2	28.61 Million PLN	0.79%
2017 Q1	28.38 Million PLN	-40.28%
2016 Q2	30.03 Million PLN	-28.18%
2016 FY	128.77 Million PLN	19.75%
2016 Q4	47.53 Million PLN	112.29%
2016 Q1	41.82 Million PLN	39.45%
2016 Q3	22.39 Million PLN	-25.46%
2015 Q4	29.99 Million PLN	5.29%
2015 FY	107.54 Million PLN	9.62%
2015 Q3	28.48 Million PLN	0.0%
2014 FY	98.09 Million PLN	36.93%
2013 FY	71.64 Million PLN	78.61%
2012 FY	40.1 Million PLN	0.0%

Peer Revenue Comparison of Celon Pharma S.A.

Name	Revenue	Revenue Difference